Pfizer is exploring options for some early stage treatments for rare diseases and cancer in a bid to focus on high-impact medicines and vaccines, the company said on Thursday.
The U.S. drugmaker said these options included collaborations with other drug developers for these medicines, or establishing a new company. Pfizer now plans to focus on internally developing rare disease treatments using technologies such as gene editing, it said, while exploring external opportunities for early-stage gene therapy programs and its cancer-focused research facility in Boulder, Colorado.
Pfizer Inc is exploring options for some early-stage treatments for rare diseases and cancer in a bid to focus on "high-impact" medicines and vaccines, the company said on Thursday.